Myelodysplastic syndrome due to somatic GATA1 mutation.

Myelodysplastic syndrome due to somatic GATA1 mutation.

Bibliografske podrobnosti
Main Authors:	Freson, K, Vyas, P, Thys, C, Wittevrongel, C, De Vos, R, Van Geet, C
Format:	Conference item
Izdano:	2004

Podobne knjige/članki

A Myelodysplastic Syndrome Associated with a Clonal GATA1 Mutation.
od: Freson, K, et al.
Izdano: (2008)

PLATELET DYSFUNCTION AND MDS FEATURES DUE TO NOVEL SOMATIC GATA1 MUTATION
od: Freson, K, et al.
Izdano: (2010)

The transcription factor GATA1 regulates NBEAL2 expression through a long-distance enhancer
od: Anouck Wijgaerts, et al.
Izdano: (2017-04-01)

Somatic mutations in children with GATA2-associated myelodysplastic syndrome who lack other features of GATA2 deficiency
od: Kevin E. Fisher, et al.
Izdano: (2017-02-01)

GATA1 gene variants associated with thrombocytopenia and anemia
od: Kathleen Freson, et al.
Izdano: (2017-10-01)

GATA1 and cooperating mutations in myeloid leukaemia of Down syndrome
od: Garnett, C, et al.
Izdano: (2019)

GATA2 and secondary mutations in familial myelodysplastic syndromes and pediatric myeloid malignancies
od: Xinan Wang, et al.
Izdano: (2015-10-01)

Defective nuclear localization of Hsp70 is associated with dyserythropoiesis and GATA-1 cleavage in myelodysplastic syndromes.
od: Frisan, E, et al.
Izdano: (2012)

Can somatic GATA2 mutation mimic germ line GATA2 mutation?
od: Mallika Sekhar, et al.
Izdano: (2018-04-01)

Analysis of GATA-1 mutations in chronic myeloid leukaemia.
od: Halsey, C, et al.
Izdano: (2006)

Severe TMD/AMKL with GATA1 mutation in a stillborn fetus with Down syndrome.
od: Heald, B, et al.
Izdano: (2007)

PB1916: SOMATIC MUTATIONS ASSOCIATED WITH MYELODYSPLASTIC SYNDROME IN RUSSIAN PATIENTS
od: A. Kohno, et al.
Izdano: (2022-06-01)

GATA1 Mutation In Transient Leukemia (TL) and Myeloid Leukemia of Down Syndrome
od: Reinhardt, K, et al.
Izdano: (2010)

GATA1 Mutation In Transient Leukemia (TL) and Myeloid Leukemia of Down Syndrome
od: Reinhardt, K, et al.
Izdano: (2010)

Natural history of GATA-1 mutations in Down syndrome.
od: Ahmed, M, et al.
Izdano: (2003)

GATA1 mutational analysis in chronic myeloid leukaemia.
od: Halsey, C, et al.
Izdano: (2007)

Natural history of GATA1 mutations in Down syndrome.
od: Ahmed, M, et al.
Izdano: (2004)

Analysis of GATA1 mutations in Down syndrome transient myeloproliferative disorder and myeloid leukemia.
od: Alford, K, et al.
Izdano: (2011)

Somatic Mutations in Myelodysplastic Syndrome Patients in the Context of Allogeneic Stem Cell Transplantation
od: Olga Blau, et al.
Izdano: (2016-11-01)

CONTRIBUTION OF SOMATIC MUTATIONS IN THE RISK STRATIFICATION OF MYELODYSPLASTIC NEOPLASMS
od: FK Marques, et al.
Izdano: (2023-10-01)

Are somatic mutations predictive of response to erythropoiesis stimulating agents in lower risk myelodysplastic syndromes?
od: Olivier Kosmider, et al.
Izdano: (2016-07-01)

Two novel somatic mutations of the ATRX gene in female patients with acquired alpha thalassemia of myelodysplastic syndrome (ATMDS).
od: Haas, P, et al.
Izdano: (2006)

GATA1 mutation analysis demonstrates two distinct primary leukemias in a child with down syndrome; implications for leukemogenesis.
od: Hellebostad, M, et al.
Izdano: (2005)

Somatic mutations of calreticulin in myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms
od: Luca Malcovati, et al.
Izdano: (2014-11-01)

Inappropriately low hepcidin levels in patients with myelodysplastic syndrome carrying a somatic mutation of SF3B1
od: Ilaria Ambaglio, et al.
Izdano: (2013-03-01)

Impaired human hematopoiesis due to a cryptic intronic GATA1 splicing mutation
od: Abdulhay, N, et al.
Izdano: (2019)

Mutated ASXL1 and number of somatic mutations as possible indicators of progression to chronic myelomonocytic leukemia of myelodysplastic syndromes with single or multilineage dysplasia
od: Ana Valencia-Martinez, et al.
Izdano: (2017-09-01)

Transcriptional regulation of GATA1
od: Drissen, R, et al.
Izdano: (2007)

GATA1-mediated megakaryocyte differentiation and growth control can be uncoupled and mapped to different domains in GATA1
od: Kuhl, C, et al.
Izdano: (2005)

Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.
od: Malcovati, L, et al.
Izdano: (2011)

Outcomes and effect of somatic mutations after erythropoiesis stimulating agents in patients with lower-risk myelodysplastic syndromes
od: Juan Carlos Caballero, et al.
Izdano: (2024-01-01)

Somatic mutations and DNA methylation identify a subgroup of poor prognosis within lower‐risk myelodysplastic syndromes
od: David Rombaut, et al.
Izdano: (2025-01-01)

Clinical and biological implications of driver mutations in myelodysplastic syndromes.
od: Papaemmanuil, E, et al.
Izdano: (2013)

Collaborating constitutive and somatic genetic events in myeloid malignancies: ASXL1 mutations in patients with germline GATA2 mutations
od: Jean-Baptiste Micol, et al.
Izdano: (2014-02-01)

Deletion of the major GATA1 enhancer HS 1 does not affect eosinophil GATA1 expression and eosinophil differentiation.
od: Guyot, B, et al.
Izdano: (2004)

GATA1-mediated megakaryocyte differentiation and growth control can be uncoupled and mapped to different domains in GATA1.
od: Kuhl, C, et al.
Izdano: (2005)

Loss of B cells and their precursors is the most constant feature of GATA-2 deficiency in childhood myelodysplastic syndrome
od: Michaela Nováková, et al.
Izdano: (2016-06-01)

Somatic point mutations in RUNX1/CBFA2/AML1 are common in high-risk myelodysplastic syndrome, but not in myelofibrosis with myeloid metaplasia
od: Steensma, D, et al.
Izdano: (2004)

Somatic point mutations in RUNX1/CBFA2/AML1 are common in high-risk myelodysplastic syndrome, but not in myelofibrosis with myeloid metaplasia.
od: Steensma, D, et al.
Izdano: (2005)

Abnormalities in the myeloid progenitor compartment in Down syndrome fetal liver precede acquisition of GATA1 mutations.
od: Tunstall-Pedoe, O, et al.
Izdano: (2008)